What does PHARMACIE VAN ACHTER do?

PHARMACIE VAN ACHTER is a pharmacy in Elsene. Private Limited, started on 22 December 2016, 1 establishment.

What is the address of PHARMACIE VAN ACHTER?

The registered office of PHARMACIE VAN ACHTER is located at Waterloose Steenweg 564, 1050 Elsene.

Is PHARMACIE VAN ACHTER still active?

Yes. According to the CBE (3 October 2026) PHARMACIE VAN ACHTER is active, legal situation “Normale toestand”, started on 22 December 2016.

Is PHARMACIE VAN ACHTER registered on Peppol?

Yes, PHARMACIE VAN ACHTER is registered on the Peppol network with ID 0208:0667995349.

What is the enterprise number of PHARMACIE VAN ACHTER?

The enterprise number of PHARMACIE VAN ACHTER is BE0667995349.

When was PHARMACIE VAN ACHTER founded?

PHARMACIE VAN ACHTER was founded on 22 December 2016.

Who are the directors of PHARMACIE VAN ACHTER?

According to the 2025 annual accounts, the directors of PHARMACIE VAN ACHTER are: Nathalie VAN ACHTER.

Is PHARMACIE VAN ACHTER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE VAN ACHTER make in 2025?

PHARMACIE VAN ACHTER posted a profit after taxes of € 1,068 in financial year 2025.

What is the revenue of PHARMACIE VAN ACHTER?

As a small company, PHARMACIE VAN ACHTER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 50,423.

PHARMACIE VAN ACHTER (Private Limited) - Elsene

Dossier PHARMACIE VAN ACHTER, printed on 3 October 2026 from databakkes.be/en/0667995349/pharmacie-van-achter. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 55 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE VAN ACHTER from Elsene, company number BE0667995349, closed financial year 2025 with a result of € 1,068 after tax. For that financial year PHARMACIE VAN ACHTER recorded a gross margin of € 50,423 and equity of € 33,960. Compared with financial year 2024, the result moved from € 7,986 to € 1,068. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Growing

€ 33,960

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 1,068

▼ 87% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 55,874

▲ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 15,360.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 17,737

▼ 11% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 847

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 48,252

▲ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,397

▼ 35% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 59,360 Gross margin 2022: € 59,360 First fiscal year in the series	€ 45,519 Gross margin 2023: € 45,519 ▼ 23% vs 2022 (€ 59,360) Unfavourable step	€ 45,651 Gross margin 2024: € 45,651 Unchanged (€ 45,519) Favourable step	€ 50,423 Gross margin 2025: € 50,423 ▲ 10% vs 2024 (€ 45,651) Favourable step	▲ 10%
Profit after taxes	€ 12,473 Profit after taxes 2022: € 12,473 First fiscal year in the series	€ 847 Profit after taxes 2023: € 847 ▼ 93% vs 2022 (€ 12,473) Unfavourable step	€ 7,986 Profit after taxes 2024: € 7,986 ▲ € 7,138 vs 2023 (€ 847) Favourable step	€ 1,068 Profit after taxes 2025: € 1,068 ▼ 87% vs 2024 (€ 7,986) Unfavourable step	▼ 87%
Equity	€ 44,059 Equity 2022: € 44,059 First fiscal year in the series	€ 44,906 Equity 2023: € 44,906 ▲ 2% vs 2022 (€ 44,059) Favourable step	€ 32,892 Equity 2024: € 32,892 ▼ 27% vs 2023 (€ 44,906) Unfavourable step	€ 33,960 Equity 2025: € 33,960 ▲ 3% vs 2024 (€ 32,892) Favourable step	▲ 3%
Total debts	€ 190,890 Total debts 2022: € 190,890 First fiscal year in the series	€ 176,117 Total debts 2023: € 176,117 ▼ 8% vs 2022 (€ 190,890) Favourable step	€ 171,774 Total debts 2024: € 171,774 ▼ 2% vs 2023 (€ 176,117) Favourable step	€ 159,489 Total debts 2025: € 159,489 ▼ 7% vs 2024 (€ 171,774) Favourable step	▼ 7%
Cash	€ 31,478 Cash 2022: € 31,478 First fiscal year in the series	€ 44,473 Cash 2023: € 44,473 ▲ 41% vs 2022 (€ 31,478) Favourable step	€ 42,188 Cash 2024: € 42,188 ▼ 5% vs 2023 (€ 44,473) Unfavourable step	€ 55,874 Cash 2025: € 55,874 ▲ 32% vs 2024 (€ 42,188) Favourable step	▲ 32%
Retained profit	€ 25,459 Retained profit 2022: € 25,459 First fiscal year in the series	€ 26,306 Retained profit 2023: € 26,306 ▲ 3% vs 2022 (€ 25,459) Favourable step	€ 14,292 Retained profit 2024: € 14,292 ▼ 46% vs 2023 (€ 26,306) Unfavourable step	€ 15,360 Retained profit 2025: € 15,360 ▲ 7% vs 2024 (€ 14,292) Favourable step	▲ 7%
Dividend	€ 40,000 Dividend 2022: € 40,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 40,000) Unchanged	€ 20,000 Dividend 2024: € 20,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 20,000) Unchanged	▼ 100%
Bank debt	€ 13,185 Bank debt 2022: € 13,185 First fiscal year in the series	€ 3,563 Bank debt 2023: € 3,563 ▼ 73% vs 2022 (€ 13,185) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 3,563) Favourable step	€ 847 Bank debt 2025: € 847 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 234,949 Balance sheet total 2022: € 234,949 First fiscal year in the series	€ 221,023 Balance sheet total 2023: € 221,023 ▼ 6% vs 2022 (€ 234,949) Unchanged	€ 204,666 Balance sheet total 2024: € 204,666 ▼ 7% vs 2023 (€ 221,023) Unchanged	€ 193,448 Balance sheet total 2025: € 193,448 ▼ 5% vs 2024 (€ 204,666) Unchanged	▼ 5%

Key figures of PHARMACIE VAN ACHTER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE VAN ACHTER?

What happened at PHARMACIE VAN ACHTER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 16, 2026 New annual accounts for financial year 2025: profit of € 1,068 (▼ 87% vs 2024). Source: NBB ↗
Dec 22, 2016 New establishment in Elsene. KBO
2016 Nathalie VAN ACHTER became a director. NBB
Dec 22, 2016 Start of the company according to the CBE. KBO

In short

From € 12,473 profit in 2022 to € 1,068 profit in 2025.

Paid € 10,232 in corporate taxes since 2022.

Best year ever: 2022, with € 12,473 profit.

Paid out € 60,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE VAN ACHTER? We notify you, reason included.

Follow PHARMACIE VAN ACHTER

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Nathalie VAN ACHTER

PHARMACIE VAN ACHTER

Behind PHARMACIE VAN ACHTER is Nathalie VAN ACHTER.

See the full network in the app

Directors

According to the 2025 annual accounts

Nathalie VAN ACHTER

Administrator-manager

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Waterloose Steenweg 564

1050 Elsene

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0667.995.349

VAT number

BE 0667.995.349

Registered office

Waterloose Steenweg 564, 1050 Elsene

Names & denominations

PHARMACIE VAN ACHTER

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 December 2016

Peppol

Active · Active since 30 Apr 2024

Contact

[email protected]

Activities · NACE

Detailhandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE VAN ACHTER

Warning lights

Financials

What happened to PHARMACIE VAN ACHTER?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions